Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
The Lausanne University Hospital (CHUV) has reported the initial dosing of a patient in a phase II clinical study invest…
Oncology Drugs Market is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2025
According to the National Cancer Institute, cancer survival rates over a five-year period in the US have demonstrated a…
Oncology Drugs Market is Set to Exhibit Robust Revenue Growth During the Forecast Period (2021-2025)
According to the National Cancer Institute, cancer survival rates over a five-year period in the US have demonstrated a…
Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory in Heidelberg and Stanford University have found the cause of…
UCB announces approval of Cimzia in China
After receiving priority review in 2018, CIMZIA® (certolizumab pegol) is now approved in China for the treatment of Mode…
Regine Sixt presents the Sixt Global Convention in Malta
An event under the patronage of the President of Malta, Marie Louise Coleiro Preca A delegation of around 500 Sixt…
Medigene reports results of first six months 2016
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T…
Medigene reports results of first quarter 2016
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T…
Clinical data of Medigene's dendritic cell (DC) vaccines in AML presented at CIMT conference
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immune-oncology company focusing on the development of T…
Clinical data from IIT using Medigene's dendritic cell (DC) vaccines in prostate cancer presented at AACR conference
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immune-oncology company focusing on the development of T…